Skip to main content

Closed

NVAX: Novavax, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+22.6% / yr

Operating margin-11.2%

ROIC-9.5%

Financially safe

Stretched

Debt / equity-2.04×

Interest coverage-5.6×

Current ratio2.48×

Novavax, Inc.

NVAXNASDAQ Global Select·USD·Closed

Novavax, Inc.

NVAXNASDAQ·USD·Closed

$7.32

−1.61%

$7.32

−$0.12 (1.61%)

52W Range

19thpctl

Volume

0.67×avg

Mkt Cap

1.20BUSD

P/E

-13.6TTM

Div Yield

–ann

52W Range

19thpctl

Volume

0.67×avg

Market Cap

1.20BUSD

P/E Ratio

-13.6TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings